Global Panitumumab Market Growth (Status and Outlook) 2023-2029

March 2023 | 63 pages | ID: G6A0B86FC37EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Panitumumab (INN), formerly ABX-EGF, is a fully human monoclonal antibody specific to the epidermal growth factor receptor (also known as EGF receptor, EGFR, ErbB-1 and HER1 in humans).

LPI (LP Information)' newest research report, the “Panitumumab Industry Forecast” looks at past sales and reviews total world Panitumumab sales in 2022, providing a comprehensive analysis by region and market sector of projected Panitumumab sales for 2023 through 2029. With Panitumumab sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Panitumumab industry.

This Insight Report provides a comprehensive analysis of the global Panitumumab landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Panitumumab portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Panitumumab market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Panitumumab and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Panitumumab.

The global Panitumumab market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Panitumumab is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Panitumumab is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Panitumumab is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Panitumumab players cover Amgen. etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Panitumumab market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type

• 100 mg/5 mL single-dose vials
• 400 mg/20 mLsingle-dose vials

Segmentation by application

• Hospital
• Drug store

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Amgen

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Panitumumab Market Size 2018-2029
  2.1.2 Panitumumab Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Panitumumab Segment by Type
  2.2.1 100 mg/5 mL single-dose vials
  2.2.2 400 mg/20 mLsingle-dose vials
2.3 Panitumumab Market Size by Type
  2.3.1 Panitumumab Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global Panitumumab Market Size Market Share by Type (2018-2023)
2.4 Panitumumab Segment by Application
  2.4.1 Hospital
  2.4.2 Drug store
2.5 Panitumumab Market Size by Application
  2.5.1 Panitumumab Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global Panitumumab Market Size Market Share by Application (2018-2023)

3 PANITUMUMAB MARKET SIZE BY PLAYER

3.1 Panitumumab Market Size Market Share by Players
  3.1.1 Global Panitumumab Revenue by Players (2018-2023)
  3.1.2 Global Panitumumab Revenue Market Share by Players (2018-2023)
3.2 Global Panitumumab Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 PANITUMUMAB BY REGIONS

4.1 Panitumumab Market Size by Regions (2018-2023)
4.2 Americas Panitumumab Market Size Growth (2018-2023)
4.3 APAC Panitumumab Market Size Growth (2018-2023)
4.4 Europe Panitumumab Market Size Growth (2018-2023)
4.5 Middle East & Africa Panitumumab Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas Panitumumab Market Size by Country (2018-2023)
5.2 Americas Panitumumab Market Size by Type (2018-2023)
5.3 Americas Panitumumab Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Panitumumab Market Size by Region (2018-2023)
6.2 APAC Panitumumab Market Size by Type (2018-2023)
6.3 APAC Panitumumab Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Panitumumab by Country (2018-2023)
7.2 Europe Panitumumab Market Size by Type (2018-2023)
7.3 Europe Panitumumab Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Panitumumab by Region (2018-2023)
8.2 Middle East & Africa Panitumumab Market Size by Type (2018-2023)
8.3 Middle East & Africa Panitumumab Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL PANITUMUMAB MARKET FORECAST

10.1 Global Panitumumab Forecast by Regions (2024-2029)
  10.1.1 Global Panitumumab Forecast by Regions (2024-2029)
  10.1.2 Americas Panitumumab Forecast
  10.1.3 APAC Panitumumab Forecast
  10.1.4 Europe Panitumumab Forecast
  10.1.5 Middle East & Africa Panitumumab Forecast
10.2 Americas Panitumumab Forecast by Country (2024-2029)
  10.2.1 United States Panitumumab Market Forecast
  10.2.2 Canada Panitumumab Market Forecast
  10.2.3 Mexico Panitumumab Market Forecast
  10.2.4 Brazil Panitumumab Market Forecast
10.3 APAC Panitumumab Forecast by Region (2024-2029)
  10.3.1 China Panitumumab Market Forecast
  10.3.2 Japan Panitumumab Market Forecast
  10.3.3 Korea Panitumumab Market Forecast
  10.3.4 Southeast Asia Panitumumab Market Forecast
  10.3.5 India Panitumumab Market Forecast
  10.3.6 Australia Panitumumab Market Forecast
10.4 Europe Panitumumab Forecast by Country (2024-2029)
  10.4.1 Germany Panitumumab Market Forecast
  10.4.2 France Panitumumab Market Forecast
  10.4.3 UK Panitumumab Market Forecast
  10.4.4 Italy Panitumumab Market Forecast
  10.4.5 Russia Panitumumab Market Forecast
10.5 Middle East & Africa Panitumumab Forecast by Region (2024-2029)
  10.5.1 Egypt Panitumumab Market Forecast
  10.5.2 South Africa Panitumumab Market Forecast
  10.5.3 Israel Panitumumab Market Forecast
  10.5.4 Turkey Panitumumab Market Forecast
  10.5.5 GCC Countries Panitumumab Market Forecast
10.6 Global Panitumumab Forecast by Type (2024-2029)
10.7 Global Panitumumab Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 Amgen
  11.1.1 Amgen Company Information
  11.1.2 Amgen Panitumumab Product Offered
  11.1.3 Amgen Panitumumab Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 Amgen Main Business Overview
  11.1.5 Amgen Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Panitumumab Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of 100 mg/5 mL single-dose vials
Table 3. Major Players of 400 mg/20 mLsingle-dose vials
Table 4. Panitumumab Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Panitumumab Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Panitumumab Market Size Market Share by Type (2018-2023)
Table 7. Panitumumab Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Panitumumab Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Panitumumab Market Size Market Share by Application (2018-2023)
Table 10. Global Panitumumab Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Panitumumab Revenue Market Share by Player (2018-2023)
Table 12. Panitumumab Key Players Head office and Products Offered
Table 13. Panitumumab Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Panitumumab Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Panitumumab Market Size Market Share by Regions (2018-2023)
Table 18. Global Panitumumab Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Panitumumab Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Panitumumab Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Panitumumab Market Size Market Share by Country (2018-2023)
Table 22. Americas Panitumumab Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Panitumumab Market Size Market Share by Type (2018-2023)
Table 24. Americas Panitumumab Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Panitumumab Market Size Market Share by Application (2018-2023)
Table 26. APAC Panitumumab Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Panitumumab Market Size Market Share by Region (2018-2023)
Table 28. APAC Panitumumab Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Panitumumab Market Size Market Share by Type (2018-2023)
Table 30. APAC Panitumumab Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Panitumumab Market Size Market Share by Application (2018-2023)
Table 32. Europe Panitumumab Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Panitumumab Market Size Market Share by Country (2018-2023)
Table 34. Europe Panitumumab Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Panitumumab Market Size Market Share by Type (2018-2023)
Table 36. Europe Panitumumab Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Panitumumab Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Panitumumab Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Panitumumab Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Panitumumab Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Panitumumab Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Panitumumab Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Panitumumab Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Panitumumab
Table 45. Key Market Challenges & Risks of Panitumumab
Table 46. Key Industry Trends of Panitumumab
Table 47. Global Panitumumab Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Panitumumab Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Panitumumab Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Panitumumab Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Amgen Details, Company Type, Panitumumab Area Served and Its Competitors
Table 52. Amgen Panitumumab Product Offered
Table 53. Amgen Panitumumab Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Amgen Main Business
Table 55. Amgen Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Panitumumab Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Panitumumab Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Panitumumab Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Panitumumab Sales Market Share by Country/Region (2022)
Figure 8. Panitumumab Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Panitumumab Market Size Market Share by Type in 2022
Figure 10. Panitumumab in Hospital
Figure 11. Global Panitumumab Market: Hospital (2018-2023) & ($ Millions)
Figure 12. Panitumumab in Drug store
Figure 13. Global Panitumumab Market: Drug store (2018-2023) & ($ Millions)
Figure 14. Global Panitumumab Market Size Market Share by Application in 2022
Figure 15. Global Panitumumab Revenue Market Share by Player in 2022
Figure 16. Global Panitumumab Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Panitumumab Market Size 2018-2023 ($ Millions)
Figure 18. APAC Panitumumab Market Size 2018-2023 ($ Millions)
Figure 19. Europe Panitumumab Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Panitumumab Market Size 2018-2023 ($ Millions)
Figure 21. Americas Panitumumab Value Market Share by Country in 2022
Figure 22. United States Panitumumab Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Panitumumab Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Panitumumab Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Panitumumab Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Panitumumab Market Size Market Share by Region in 2022
Figure 27. APAC Panitumumab Market Size Market Share by Type in 2022
Figure 28. APAC Panitumumab Market Size Market Share by Application in 2022
Figure 29. China Panitumumab Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Panitumumab Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Panitumumab Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Panitumumab Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Panitumumab Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Panitumumab Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Panitumumab Market Size Market Share by Country in 2022
Figure 36. Europe Panitumumab Market Size Market Share by Type (2018-2023)
Figure 37. Europe Panitumumab Market Size Market Share by Application (2018-2023)
Figure 38. Germany Panitumumab Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Panitumumab Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Panitumumab Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Panitumumab Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Panitumumab Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Panitumumab Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Panitumumab Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Panitumumab Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Panitumumab Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Panitumumab Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Panitumumab Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Panitumumab Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Panitumumab Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Panitumumab Market Size 2024-2029 ($ Millions)
Figure 52. APAC Panitumumab Market Size 2024-2029 ($ Millions)
Figure 53. Europe Panitumumab Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Panitumumab Market Size 2024-2029 ($ Millions)
Figure 55. United States Panitumumab Market Size 2024-2029 ($ Millions)
Figure 56. Canada Panitumumab Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Panitumumab Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Panitumumab Market Size 2024-2029 ($ Millions)
Figure 59. China Panitumumab Market Size 2024-2029 ($ Millions)
Figure 60. Japan Panitumumab Market Size 2024-2029 ($ Millions)
Figure 61. Korea Panitumumab Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Panitumumab Market Size 2024-2029 ($ Millions)
Figure 63. India Panitumumab Market Size 2024-2029 ($ Millions)
Figure 64. Australia Panitumumab Market Size 2024-2029 ($ Millions)
Figure 65. Germany Panitumumab Market Size 2024-2029 ($ Millions)
Figure 66. France Panitumumab Market Size 2024-2029 ($ Millions)
Figure 67. UK Panitumumab Market Size 2024-2029 ($ Millions)
Figure 68. Italy Panitumumab Market Size 2024-2029 ($ Millions)
Figure 69. Russia Panitumumab Market Size 2024-2029 ($ Millions)
Figure 70. Spain Panitumumab Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Panitumumab Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Panitumumab Market Size 2024-2029 ($ Millions)
Figure 73. Israel Panitumumab Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Panitumumab Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Panitumumab Market Size 2024-2029 ($ Millions)
Figure 76. Global Panitumumab Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Panitumumab Market Size Market Share Forecast by Application (2024-2029)